AAN 2022

April 02-07, 2022
Seattle, WA

74th Annual Meeting of the American Academy of Neurology
Explore more Neuroscience congress materials
Material Type

Results(12)

Neuroscience
Symptom Severity and Treatment Satisfaction in Patients With Idiopathic Hypersomnia: the Real World Idiopathic Hypersomnia Outcomes Study (ARISE)
Author(s): Logan Schneider, MD Joanne Stevens, BA Aatif M. Husain, MD Diane Ito, MA Wayne Macfadden, MD Douglas S. Fuller, MS Phyllis Zee, MD, PhD
Neuroscience
View Poster
CardioVascular Burden Of Narcolepsy Disease (CV-BOND): A Real-World Evidence Study
Author(s): Rami H. Ben-Joseph, PhD Ragy Saad, MS Jed Black, MD Elizabeth C. Dabrowski, MS Ben Taylor, PhD, MSc Sophia Gallucci Virend K. Somers, MD, PhD4
Neuroscience
View Oral Presentation
Non-Seizure-Related Outcomes With Real-World Use of Cannabidiol (CBD) in Lennox-GastautSyndrome and Dravet Syndrome: BECOME, A Caregiver Survey
Author(s): Ann T. Berg PhD, Northwestern University Feinberg School of Medicine
Neuroscience
View Poster
Long-Term Efficacy and Safety of Lower-Sodium Oxybate in a Placebo-Controlled, Double-Blind, Randomized Withdrawal Study in Adults With Idiopathic Hypersomnia
Author(s): Nancy Foldvary-Schaefer, DO, MS Richard K. Bogan, MD Isabelle Arnulf, MD, PhD Michael J. Thorpy, MD Patricia Chandler, MD Luke Hickey, MSc Jed Black, MD Yves Dauvilliers, MD, PhD
Neuroscience
View Poster
Efficacy and Safety of Cannabidiol (CBD) Dose Adjustment in Patients With Lennox-Gastaust Syndrome (LGS): Post Hoc Analysis of Phase 3 Randomized Controlled Trial (RCT) GWPCARE3 and Open-Label Extension (OLE) Trial GWPCARE5
Author(s): Elaine Wirrell MD, Divisions of Child and Adolescent Neurology and Epilepsy, Mayo Clinic
Neuroscience
View Poster
Impairment in Functioning and Quality of Life in Patients With Idiopathic Hypersomnia: the Real World Idiopathic Hypersomnia Outcomes Study (ARISE)
Author(s): Logan Schneider, MD Joanne Stevens, BA Aatif M. Husain, MD Diane Ito, MA Wayne Macfadden, MD Douglas S. Fuller, MS Phyllis Zee, MD, PhD
Neuroscience
View Oral Presentation
Timing and Duration of Treatment-Emergent Adverse Events in a Clinical Trial of Lower-Sodium Oxybate in Participants With Narcolepsy With Cataplexy
Author(s): Richard K. Bogan, MD Nancy Foldvary-Schaefer, DO, MS Roman Skowronski, MD, PhD Abby Chen, MS Michael J. Thorpy, MD
Neuroscience
View Poster
Effect of Add-on Cannabidiol (CBD) on Seizure Frequency and Seizure-Free Intervals in Patients With Seizures Associated With Tuberous Sclerosis Complex (TSC): Phase 3 Trial GWPCARE6 Post Hoc Analysis
Author(s): Elizabeth Thiele MD, PhD, Massachusetts General Hospital
Neuroscience
View Poster
Psychometric Evaluation of the Idiopathic Hypersomnia Severity Scale
Author(s): Benjamin Banderas, BS Susan Morris, PhD Luke Hickey, MSc Caitlyn Lowe, BS Ethan Arenson, PhD Junji Lin, PhD Patricia Chandler, MD Yves Dauvilliers, MD, PhD
Neuroscience
View Poster